Recent News

In crowded field of psychedelic startups, Filament CEO makes case for ‘natural’ drugs

The Associated Press

November 13, 2023

Filament CEO Ben Lightburn was interviewed by the Associated Press and explained why Filament is focused on extracting compounds like psilocybin and mescaline from natural sources, like magic mushrooms and cacti, rather than synthesizing them.